Premium
Letter: tofacitinib in treatment‐refractory ulcerative colitis—a single centre real‐world experience in Australia. Authors' reply
Author(s) -
Biemans Vince B. C.,
Straatmijer Tessa,
Hoentjen Frank,
Pierik Marieke J.
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16505
Subject(s) - tofacitinib , ulcerative colitis , medicine , refractory (planetary science) , gastroenterology , disease , rheumatoid arthritis , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom